54
Participants
Start Date
September 16, 2021
Primary Completion Date
October 22, 2024
Study Completion Date
October 22, 2024
tafasitamab
tafasitamab will be administered at a protocol defined dose once a week for cycles 1-3 and every other week from cycle 4 until progression.
parsaclisib
parsaclisib will be administered at protocol defined dose for cycles 1 through disease progression.
Clinical Research Alliance, New Hyde Park
Hospital Universitario San Cecilio, Granada
Jefferson University Hospitals, Philadelphia
Irccs Istituto Clinico Humanitas, Rozzano
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Cancer Center For Blood Disorders, Bethesda
Hospital Universitario 12 de Octubre, Madrid
Centro Integral Oncologico Clara Campal (Ciocc), Madrid
Hospital Puerta de Hierro, Majadahonda
Hospital Universitario Quironsalud Madrid, Madrid
University Hospital Brest, Brest
Hospital Universitario Central de Asturias, Oviedo
University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham
Justus-Liebig University, Giessen
Hospital Clinico Universitario de Salamanca, Salamanca
Hospital Universitario Marques de Valdecilla, Santander
S Orsolas University Hospital Seragnoli Institute of Hematology, Bologna
Norton Cancer Institute, Louisville
Hospital Universitario Virgen Del Rocio, Seville
Ohio State University, Columbus
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu, Nantes
Hospital General Universitario de Valencia, Valencia
Indiana Blood and Marrow Transplantation, Indianapolis
Community Health Network, Inc., Indianapolis
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori, Meldola
University of Michigan, Ann Arbor
Ospedale Santa Maria Delle Croci, Ravenna
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz
Azienda Ospedaliero Universitaria Pisana, Pisa
Centre Henri Becquerel, Rouen
University Medical Center Freiburg, Freiburg im Breisgau
Istituto Nazionale Tumori Irccs Fondazione Pascale, Naples
University of Southern California, Los Angeles
Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello, Palermo
Institut Gustave Roussy, Villejuif
University Hospital Wurzburg, Würzburg
Ordensklinikum Linz Gmbh Elisabethinen, Linz
Landeskrankenhaus Salzburg, Salzburg
Hanusch-Krankenhaus Der Wiener Gebietskrankenkasse, Vienna
Institut Jules Bordet, Brussels
Grand Hospital de Charleroi, Charleroi
Universitair Ziekenhuis Antwerpen (Uza), Edegem
Az Groeninge Campus Kennedylaan, Kortrijk
Universitair Ziekenhuis (Uz) Leuven, Leuven
AZ DELTA, Roeselare
Hospital General Unviersitario de Alicante, Alicante
Hospital General Universitario Vall D Hebron, Barcelona
Hopital Sant Pau, Barcelona
Ico Institut Catala D Oncologia, Barcelona
Lead Sponsor
Incyte Corporation
INDUSTRY